These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 25088441)
1. The intractable intra-abdominal hemorrhage with unknown etiology in a patient with severe hemophilia A. Morichika K; Tomoyose T; Nishi Y; Nakachi S; Fukushima T; Masuzaki H Am J Emerg Med; 2015 Jan; 33(1):129.e1-3. PubMed ID: 25088441 [TBL] [Abstract][Full Text] [Related]
3. Life-threatening mediastinal-retroperitoneal hemorrhage in a child with moderate hemophilia A and high inhibitor titer: successful management with recombinant activated factor VII. Ylmaz S; Oren H; Irken G; Atabay B; Duman M; Ylmaz E; Cakmakç H J Pediatr Hematol Oncol; 2005 Jul; 27(7):400-2. PubMed ID: 16012333 [TBL] [Abstract][Full Text] [Related]
4. Carotid artery haemorrhage: an uncommon complication of constipation in a patient with severe haemophilia A. Shortt J; Street AM Eur J Haematol; 2006 Dec; 77(6):544. PubMed ID: 16981906 [No Abstract] [Full Text] [Related]
5. Hydatid cyst surgery complicated by hemorrhage resistant to activated recombinant factor VII, in a hemophiliac A patient with an inhibitor. Nabil S; Bentalha A; Jaiteh L; El Khorassani M; El Koraichi A; El Kettani SE Blood Coagul Fibrinolysis; 2016 Sep; 27(6):724-6. PubMed ID: 26761579 [TBL] [Abstract][Full Text] [Related]
6. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]. Levi M; Friederich PW; van der Meer J Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665 [TBL] [Abstract][Full Text] [Related]
7. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352 [TBL] [Abstract][Full Text] [Related]
8. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia. Makris M; Hampton KK; Preston EE Am J Hematol; 2001 Jan; 66(1):67-8. PubMed ID: 11426500 [No Abstract] [Full Text] [Related]
9. Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors. Łaguna P; Mital A Adv Clin Exp Med; 2012; 21(4):519-24. PubMed ID: 23240458 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling. Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151 [TBL] [Abstract][Full Text] [Related]
11. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding. Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305 [No Abstract] [Full Text] [Related]
12. Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa. Lechner D; Eichinger S; Wanivenhaus A; Kyrle PA Haemophilia; 2010 Jul; 16(4):704-5. PubMed ID: 20398074 [No Abstract] [Full Text] [Related]
13. Prevention of bleeding in hemophilia patients with high-titer inhibitors. Leissinger CA; Konkle BA; Antunes SV Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic spontaneous intraperitoneal hemorrhage: a clinical update on abdominal apoplexy in the year 2001. Carr SR; Dinsmore RC; Wilkinson NW Am Surg; 2001 Apr; 67(4):374-6. PubMed ID: 11308008 [TBL] [Abstract][Full Text] [Related]
15. Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt. Hurst E; Talks K; Hanley J Haemophilia; 2010 Jul; 16(4):708-9. PubMed ID: 20398076 [No Abstract] [Full Text] [Related]
16. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors. Majumdar G; Savidge GF Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476 [TBL] [Abstract][Full Text] [Related]
17. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa. Schuster R; Lee SJ; Rink D Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: unusual repeated ante-partum intra-abdominal bleeding. Seoud M; Cheaib S; Birjawi G; Tawil A; Jamali F J Obstet Gynaecol Res; 2010 Feb; 36(1):183-6. PubMed ID: 20178548 [TBL] [Abstract][Full Text] [Related]
20. Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center's experience. Musallam KM; Saad GS; Majdalani MN; Muwakkit SA; Bou-Khalil PK; Aoun EG; Sawaya RA; Khalil I; Taher AT Clin Appl Thromb Hemost; 2010 Dec; 16(6):658-62. PubMed ID: 19671562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]